Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Stereotaxis, Inc.

NYSE: STXS · Industrial Applications and Services · 2 alerts · CIK 1289340

Share price
$0.8027Close, Nov 16
Market cap
$81M
Shares outstanding
100.86MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Electromedical & Electrotherapeutic ApparatusSIC 3845

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Stereotaxis, Inc. filings on SEC EDGAR ↗

4:07 PM ET 8-K
Loan & Debt

Stereotaxis $24M Debt Financing with certain accredited investors

Stereotaxis entered into a Note Purchase Agreement to issue up to $24.0 million in convertible promissory notes, with an initial $12.0 million closing on November 9, 2026. The notes bear 10% interest, mature in three years, and are convertible into common stock at an initial price of $1.21 per share.

Value
$24M
Counterparty
certain accredited investors
Term
3 years

“Our near-term priority is to drive forward two major business model transformations. The first is shifting from capital systems that require long sales and construction timelines, to having a portfolio of systems that are significantly more accessible and scalable. The second is developing and commercializing a portfolio of disposable interventional catheters that enhance the value of our robots and provide a robust recurring revenue opportunity.”

David Fischel, Chairman and CEO

“System revenue of $3 million in the quarter was up 60% compared to last year, benefiting from partial revenue recognition from the first GenesisX system in the US, the first Genesis system in China, and multiple Synchrony digital operating room systems in the US.”

David Fischel, Chairman and CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.